BioMed Research International

Volume 2013 (2013), Article ID 582957, 5 pages

http://dx.doi.org/10.1155/2013/582957

Research Article

Seroprevalence of St. Louis Encephalitis Virus and West Nile Virus (Flavivirus, Flaviviridae) in Horses, Uruguay

Analía Burgueño,¹ Lorena Spinsanti,² Luis Adrián Díaz,2,3 María Elisa Rivarola,² Juan Arbiza,¹ Marta Contigiani,² and Adriana Delfraro¹

¹Sección Virología, Facultad de Ciencias, Universidad de la República, 11400 Montevideo, Uruguay

²Laboratorio de Arbovirus, Instituto de Virología Dr. J. M. Vanella, Universidad Nacional de Córdoba, 5016 Córdoba, Argentina

³Instituto de Investigaciones Biológicas y Tecnológicas CONICET-FCEFyN, UNC, 5016 Córdoba, Argentina

Received 30 April 2013; Accepted 1 October 2013

Academic Editor: Vittorio Sambri

Copyright © 2013 Analía Burgueño et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

St. Louis encephalitis virus (SLEV) and West Nile virus (WNV) belong to the Japanese encephalitis antigenic complex (Flavivirus genus, Flaviviridae family). They show antigenic close relationships and share many similarities in their ecology. Both are responsible for serious human diseases. The aim of this study was to investigate the presence of neutralizing antibodies to these viruses in horses from Uruguay. To do this, 425 horse sera were collected in 2007 and analyzed by plaque reduction neutralization tests. As a result, 205 sera (48.2%) were found positive for SLEV, with titers ranging between 10 and 80. Two sera remained inconclusive, since they showed low titers to WNV and SLEV (10 and 20), not allowing us to demonstrate activity of WNV in our territory. This is the first report of circulation of SLEV in horses in Uruguay.

1. Introduction

Infections caused by mosquito-borne flaviviruses are among the diseases with higher incidence in the world. Most of them are asymptomatic or present an influenza-like illness; however severe cases may occur, causing central nervous system disease, coma, and/or death [1, 2].

St. Louis encephalitis virus (SLEV) and West Nile virus (WNV) are members of the Japanese encephalitis antigenic complex; they are usually maintained in cycles between birds and Culex mosquitoes; humans and horses are dead-end hosts. These viruses can cause encephalitis in humans; only WNV infection may lead to fatal encephalitis in equines. All flaviviruses are antigenically closely related, giving frequent serological cross-reactions which are exaggerated in sequential infections. Because of this, specific etiologic diagnosis may be difficult specially in areas where two or more flaviviruses are prevalent [3].

SLEV is widely distributed in the Americas. Recently, human outbreaks were reported in Argentina in 2005 and 2010 [4, 5] and in Brazil in 2006 [6]. Regarding arbovirus circulation in Uruguay, the first reports of SLEV date from the 70s and correspond to serological studies in children and adults, with 4% and 5% seroprevalence, respectively [7]. In 1997 the Ministry of Public Health of Uruguay began dengue virus surveillance through serological diagnosis in human cases and detection and control of the vector Stegomyia (Aedes) aegypti. Until today, only imported cases were diagnosed but the vector is present in several departments of the country, reinforcing the need of a close surveillance of this flavivirus [8]. More recently, in 2001, as part of dengue surveillance, a cluster of febrile illness cases were confirmed as SLEV infections [9]. In 2010 the Ministry of Public Health initiated the monitoring of viral meningoencephalitis; since then 3 cases of SLEV were serologically confirmed, all in 2012 [10].

WNV was introduced in the Americas in 1999, in the city of New York, United States [11]. Since then, the virus has moved to the south of the continent, with reports of infections in birds and equines in the Caribbean, Venezuela, Colombia, and Argentina [12–16]. No records of cases or data are available for WNV in Uruguay.

The objective of the present study was to analyze the presence of neutralizing antibodies to SLEV and WNV in equines, in order to investigate the circulation of these flaviviruses in Uruguay.

2. Materials and Methods

2.1. Study Sites

Uruguay, located in the south cone of South America, has a total surface of 176.215 km² and a population of 3.356.584 inhabitants. It is divided in 19 departments (Figure 1) and the local weather is temperate (average: 17.5°C) and humid (average: 75%) with homogeneous rainfall throughout the year. The economy is based on agriculture and livestock activities.

Figure 1: Map of Uruguay in South America, showing location of sampling sites, number of positive/number of horses sampled per department, and seroprevalence percentage (in boldface).

2.2. Sample Collection

During 2007, 425 horse serum samples were collected by the Veterinary Laboratories Division (DI.LA.VE.) “Miguel C. Rubino” (Ministry of Agriculture and Fisheries) to perform epidemiologic studies. None of the horses presented any sign of disease. Blood samples were taken from the jugular vein of animals and kept at −20°C until processed. To do the present study, a minimum of 10 sera per department were tested, belonging to 18 of the 19 departments (Figure 1). Samples from Montevideo department were not available.

2.3. Plaque Reduction Neutralization Test (PRNT)

Detection of neutralizing antibodies to SLEV and WNV was performed using plaque reduction neutralization tests (PRNT) in VERO cells as previously described [17]. SLEV strain 78V6507 [18] and WNV strain E/7229/06 [15] were used. Screening of sera was done at 1 : 10 dilution and endpoints were determined at 80% (PRNT₈₀). Positive samples were further titrated in serial dilutions beginning at 1 : 20.

3. Results

In the screening test, 207 (48.7%) of the 425 horses had neutralizing antibodies to SLEV. Positive samples were found in 17 of the 18 departments tested (all departments except for Lavalleja) (Table 1). By department, seroprevalence ranged between 0 and 75%, with the highest value corresponding to San José (18 positives from 24 tested). PRNT₈₀ titers of SLEV seropositive horse sera ranged from 10 to 160 (data available under request).

Table 1: Results of the PRNT₈₀ screening to SLEV and WNV.

Department
No. of samples analyzed
No. of SLEV positive
No. of WNV positive*

Artigas
20
6
0

Canelones
15
11
2

Cerro Largo
32
13
0

Colonia
39
27
1

Durazno
15
10
0

Flores
27
14
0

Florida
21
11
1

Lavalleja
20
0
0

Maldonado
21
10
0

Paysandú
20
11
1

Río Negro
23
8
0

Rivera
43
17
0

Rocha
22
8
0

Salto
22
12
1

San José
24
18
0

Soriano
23
11
1

Tacuarembó
28
13
0

Treinta y Tres
10
7
1

Total
425
207
8

Samples positive both to WNV and SLEV.

Of the 207 SLEV seropositive sera found in the screening, 90 were further titrated in a simultaneous test for both SLEV and WNV. No seropositive sera to WNV were detected at this stage. In view of this result, and taking into account that PRNT is a highly time and resource consuming technique, we decided not to continue with the simultaneous titration. So, all other SLEV seropositive samples in the screening () were in turn screened to WNV. After these assays, eight sera were positive for WNV at a 1 : 10 dilution. These eight sera were in turn simultaneously titrated to SLEV and WNV. As result, six sera showed a fourfold or greater difference in titer to SLEV in respect to WNV and two sera remained inconclusive (Table 2). Finally, a total of 205 samples (48.2%) were considered as SLEV positive.

Table 2: PRNT₈₀ simultaneous titration to SLEV and WNV.

Sample
Department
Antibody titer
Result

SLEV
WNV

E07/204
Salto
10
20
Inconclusive

E07/210
Canelones
80
10
SLEV

E07/211
Colonia
40
10
SLEV

E07/245
Paysandú
80
10
SLEV

E07/274
Florida
10
10
Inconclusive

E07/287
Canelones
80
10
SLEV

E07/408
Soriano
80
20
SLEV

E07/421
Treinta y Tres
40
10
SLEV

4. Discussion

We report the first evidence of neutralizing antibodies to SLEV in horses in Uruguay. SLEV transmission appears to be widely distributed in the country and has no geographic restrictions, since we found antibodies in sera from 17 of the 18 departments analyzed.

Our studies indicated a 48.2% seroprevalence for SLEV, similar to previously reported values in neighbor countries. In Argentina, Monath et al. found SLEV seroprevalence ranging from 42 to 75% [19]. More recently a study of Tauro et al. in Santa Fe province found a 12% seroprevalence, much lower than the one found by Monath. As the authors stated in their article, this seroprevalence could be underestimated due to the use of an alternative (more stringent) criterion of positivity [20].

In Brazil, Rodrigues et al. investigated the immunity of horses against SLEV in Mato Grosso do Sul State and the Brazilian Amazon region, and they found a seroprevalence of 50.9%. In turn, Pauvolid-Corrêa et al. found a seroprevalence of 43.7% in horses from the Nhecolândia subregion in South Pantanal (Central-West Brazil) [21, 22].

To minimize the cross-reaction results in this survey, we followed the Centers for Disease Control and Prevention’s (CDC) guidelines for seropositivity: when comparing sera titers to two or more viruses, a fourfold difference in PRNT is needed to identify the etiologic agent. According to this criterion, the simultaneous titration resulted in six sera seropositive to SLEV and two inconclusive. From these inconclusive sera, sample E07/204 showed a greater titer to WNV (20) than SLEV (10). These results could be due to an initial infection with WNV followed by a secondary infection with SLEV. Patiris et al. demonstrated in chickens that sequential infections with SLEV (1st) and WNV (2nd) greatly amplified antibodies to SLEV. The reverse order of infection (1st infection with WNV and 2nd infection with SLEV) produced a limited response, and titers to both viruses remained similar. In turn, titers to WNV may be considered as result of a very recent infection or a cross-reaction for an undetermined flavivirus. Lederman et al. showed that after an initial exposition to SLEV followed by a subsequent infection with WNV, detectable levels of WNV specific antibodies developed at days 9–12, with a peak at days 12–18 [23, 24].

It is noteworthy that, a year before our sampling, WNV virus was actively circulating in the region. In 2006, the virus was isolated for the first time in South America from sick horses in Argentina, and evidence of WNV activity in birds was demonstrated in Córdoba province (Argentina) in 2005 and 2006 [12, 15]. The inconclusive results regarding WNV activity reinforce the need of further studies to confirm or discard its circulation in Uruguay.

SLEV activity in horses described in this study, together with the reports of sporadic human infections and the diagnosis of three cases of SLEV meningoencephalitis (two in Montevideo and one in San José department), confirm the circulation of this virus in our country [9, 10]. Our study shows that the highest seroprevalence corresponded to San José and Canelones departments (75% and 73.3%, resp.). Although we have no data from Montevideo, it is noteworthy that San José and Canelones are bordering departments. In addition, 59% of the Uruguayan population resides in these departments, so this Southern area of the country may be at risk for future outbreaks. In turn, the relatively low number of SLEV human cases in comparison with the high seroprevalence found in horses could be due to unapparent infections or the lack of febrile syndrome surveillance. Our results highlight the need for initiating the surveillance of febrile syndromes and sustaining the monitoring of viral encephalitis in Uruguay.

Regarding arbovirus investigation in Uruguay, our lab is conducting since 2007 the molecular detection in mosquitoes. Although we still did not detect SLEV in the vectors, it is to note that Culex spp. represents the 80% of mosquitoes captured in our studies, so risk of outbreaks should not be discarded.

5. Conclusions

The results presented here show that SLEV is actively circulating in our country at a significant prevalence (48.2%). Seroprevalences ranged between 0 and 75%; San José and Canelones departments presented the highest values (75% and 73.3%, resp.). Our results do not demonstrate the circulation of WNV in Uruguay; however recent infections with this virus or circulation of another flaviviruses cannot be excluded.

Our findings, together with the sporadic SLEV infections documented in humans and the risk of introduction of dengue virus in our territory, reinforce the need of differential diagnosis of flaviviruses. With the aim of contributing to the knowledge of the ecology of flavivirus in our country, our research group is carrying out arbovirus detection in mosquitoes and initiating serologic studies in wild birds.

Acknowledgments

The authors thank María Soledad Valledor and María Angélica Solari for collecting the serum specimens and Brenda Konigheim, Javier Aguiar, Laura Tauro, and Mauricio Beranek for help in tissue cultures. Analía Burgueño works at the Sección Virología, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay. Luis Adrián Díaz is member of the Scientific Research Career at CONICET. María Elisa Rivarola is a recipient of a doctoral scholarship from CONICET and student in the Biological Sciences doctorate program at the Faculty of Exact, Physics and Natural Sciences (UNC). This study was supported by Grants BE_MOV_2009_1096, BE_MOV_2010_2014, BE_INI_2008_231, and MRC_C_ 2011_1_6, from the Agencia Nacional de Innovación e Investigación (ANII).

References

S. C. Weaver and A. D. Barrett, “Transmission cycles, host range, evolution and emergence of arboviral disease,” Nature Reviews Microbiology, vol. 2, no. 10, pp. 789–801, 2004.

W. K. Reisen, “Epidemiology of St. Louis encephalitis virus,” Advances in Virus Research, vol. 61, pp. 139–183, 2003.

D. M. Knipe and P. M. Howley, Fields Virology, Lippincott Wiliams & Wilkins, a Wolters Kluwer Business, 2007.

L. I. Spinsanti, L. A. Díaz, N. Glatstein et al., “Human outbreak of St. Louis encephalitis detected in Argentina, 2005,” Journal of Clinical Virology, vol. 42, no. 1, pp. 27–33, 2008.

A. Seijo, A. Morales, G. Poustis et al., “Outbreak of St. Louis encephalitis in the metropolitan Buenos Aires area,” Medicina B, vol. 71, no. 3, pp. 211–217, 2011.

A. Mondini, I. L. Cardeal, E. Lázaro et al., “Saint Louis encephalitis virus, Brazil,” Emerging Infectious Diseases, vol. 13, no. 1, pp. 176–178, 2007.

R. E. Somma-Moreira, J. C. Russi, M. H. de Giordano, C. A. Bauzá, G. Peluffo, and H. C. Tosi, “Arbovirus en el Uruguay,” Archivos de Pediatría del Uruguay, vol. 41, pp. 359–363, 1970.

D. Epidemiología, Boletin Epidemiológico (SE42), Ministerio de Salud Pública, 2012.

A. Delfraro, Arbovirus en Uruguay: Dengue-Diagnóstico, 2002.

D. Epidemiología, Boletín Epidemiológico (SE24), Ministerio de Salud Pública, 2012.

L. R. Petersen and J. T. Roehrig, “West Nile virus: a reemerging global pathogen,” Emerging Infectious Diseases, vol. 7, no. 4, pp. 611–614, 2001.

L. A. Diaz, N. Komar, A. Visintin et al., “West Nile virus in birds, Argentina,” Emerging Infectious Diseases, vol. 14, no. 4, pp. 689–691, 2008.

L. Berrocal, J. Peña, M. González, and S. Mattar, “West Nile virus, ecology and epidemiology of an emerging pathogen in Colombia,” Revista de Salud Publica, vol. 8, no. 2, pp. 218–228, 2006.

N. Komar and G. G. Clark, “West Nile virus activity in Latin America and the Caribbean,” Revista Panamericana de Salud Publica, vol. 19, no. 2, pp. 112–117, 2006.

M. A. Morales, M. Barrandeguy, C. Fabbri et al., “West Nile virus isolation from equines in Argentina, 2006,” Emerging Infectious Diseases, vol. 12, no. 10, pp. 1559–1561, 2006.

I. Bosch, F. Herrera, J. C. Navarro et al., “West Nile virus, Venezuela,” Emerging Infectious Diseases, vol. 13, no. 4, pp. 651–653, 2007.

E. Early, P. H. Peralta, and K. M. Johnson, “A plaque neutralization method for arboviruses,” Proceedings of the Society for Experimental Biology and Medicine, vol. 125, no. 3, pp. 741–747, 1967.

C. J. Mitchell, T. P. Monath, M. S. Sabattini, et al., “Arbovirus investigations in Argentina, 1977–1980. II. Arthropod collections and virus isolations from argentine mosquitoes,” The American Journal of Tropical Medicine and Hygiene, vol. 34, pp. 945–955, 1985.

T. P. Monath, M. S. Sabattini, R. Pauli et al., “Arbovirus investigations in Argentina, 1977–1980. IV. Serologic surveys and sentinel equine program: arthropod collections and virus isolations from argentine mosquitoes,” The American Journal of Tropical Medicine and Hygiene, vol. 34, pp. 945–955, 1985.

L. Tauro, B. Marino, L. A. Diaz et al., “Serological detection of St. Louis encephalitis virus and West Nile virus in equines from Santa Fe, Argentina,” Memórias do Instituto Oswaldo Cruz, vol. 107, no. 4, pp. 553–556, 2012.

S. G. Rodrigues, O. P. Oliva, F. A. Araujo et al., “Epidemiology of Saint Louis encephalitis virus in the Brazilian Amazon region and in the State of Mato Grosso do Sul, Brazil: elevated prevalence of antibodies in horses,” Revista Pan-Amazônica de Saúde, vol. 1, no. 1, pp. 81–86, 2010.

A. Pauvolid-Corrêa, F. N. Tavares, E. V. Costa et al., “Serologic evidence of the recent circulation of Saint Louis encephalitis virus and high prevalence of equine encephalitis viruses in horses in the Nhecolândia sub-region in South Pantanal, Central-West Brazil,” Memórias do Instituto Oswaldo Cruz, vol. 105, no. 6, pp. 829–833, 2010.

P. J. Patiris, L. F. Oceguera III, G. W. Peck, R. E. Chiles, W. K. Reisen, and C. V. Hanson, “Serologic diagnosis of West Nile and St. Louis encephalitis virus infections in domestic chickens,” The American Journal of Tropical Medicine and Hygiene, vol. 78, no. 3, pp. 434–441, 2008.

J. P. Ledermann, M. A. Lorono-Pino, C. Ellis et al., “Evaluation of widely used diagnostic tests to detect West Nile virus infections in horses previously infected with St. Louis encephalitis virus or dengue virus type 2,” Clinical and Vaccine Immunology, vol. 18, no. 4, pp. 580–587, 2011.